Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Akari Therapeutics, Plc is a biotechnology company developing precision bifunctional antibody drug conjugates (ADC) for the treatment of cancer. Utilizing its ADC discovery platform, it generates bifunctional ADC candidates and optimizes them based on the desired application to target a range of cancers. Its lead candidate, AKTX-101, targets the TROP2 receptor on cancer cells, and with a proprietary linker, delivers its novel PH1 payload directly into the tumor. PH1 is a novel bifunctional payload that is designed to disrupt RNA splicing within cancer cells, inducing tumor-specific cell death while generating immunostimulatory effects and minimizing off-target toxicity. Its pipeline includes AKTX-101 and AKTX-102, a discovery-stage ADC that pairs PH1 with an undisclosed target antibody. It is pursuing research on two additional novel payloads, such as PH5 and PH6. It also has an ADC Platform for oncology and PHP-303 program for genetic disease, liver disease and inflammation.
Find out what a historical investment in Akari Therapeutics PLC would be worth today using our AKTX stock calculator.
Buying AKTX shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Akari Therapeutics PLC in minutes.
Sign up with some I.D. and zero paperwork
Add funds to your account
Make your first investment in AKTX
What is the ticker symbol of Akari Therapeutics PLC?
The ticker symbol for Akari Therapeutics PLC is AKTX.
How much is one share of AKTX?
One share of AKTX is valued at $6.71 as of 20 November 2026.
What is the market capitalisation of Akari Therapeutics PLC AKTX?
As of 20 November 2026 Akari Therapeutics PLC has a market cap of $15.47M.
What is the 52-week high for Akari Therapeutics PLC stock?
The Akari Therapeutics PLC 52-week high stock price is $29.32.
What is the 52-week low for Akari Therapeutics PLC stock?
The Akari Therapeutics PLC 52-week low stock price is $3.02.
Can I buy AKTX shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy AKTX shares and over 13,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in AKTX on Stake
Buy AKTX from US$3 brokerage
Invest in 11,000+ U.S. stocks and ETFs
Own a slice of AKTX from only US$10 with fractional shares